Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Conditional ligands for Asian HLA variants facilitate the definition of CD8(+) T-cell responses in acute and chronic viral diseases
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Conditional ligands for Asian HLA variants facilitate the definition of CD8(+) T-cell responses in acute and chronic viral diseases
Creator
Bertoletti, Antonio
Chia, Adeline
Tan, Yee-Joo
Nadua, Karen
Gehring, Adam
Grotenbreg, Gijsbert
Leong, Nam
Tan, Anthony
Oh, Hsueh-Ling
Chang, Cynthia
Froesig, Thomas
Hadrup, Sine
Lim, Pei
Or, Ming
Toh, Kai
source
Medline; PMC
abstract
Conditional ligands have enabled the high-throughput production of human leukocyte antigen (HLA) libraries that present defined peptides. Immunomonitoring platforms typically concentrate on restriction elements associated with European ancestry, and such tools are scarce for Asian HLA variants. We report 30 novel irradiation-sensitive ligands, specifically targeting South East Asian populations, which provide 93, 63, and 79% coverage for HLA-A, -B, and -C, respectively. Unique ligands for all 16 HLA types were constructed to provide the desired soluble HLA product in sufficient yield. Peptide exchange was accomplished for all variants as demonstrated by an ELISA-based MHC stability assay. HLA tetramers with redirected specificity could detect antigen-specific CD8(+) T-cell responses against human cytomegalovirus, hepatitis B (HBV), dengue virus (DENV), and Epstein-Barr virus (EBV) infections. The potential of this population-centric HLA library was demonstrated with the characterization of seven novel T-cell epitopes from severe acute respiratory syndrome coronavirus, HBV, and DENV. Posthoc analysis revealed that the majority of responses would be more readily identified by our unbiased discovery approach than through the application of state-of-the-art epitope prediction. This flow cytometry-based technology therefore holds considerable promise for monitoring clinically relevant antigen-specific T-cell responses in populations of distinct ethnicity.
has issue date
2012-12-26
(
xsd:dateTime
)
bibo:doi
10.1002/eji.201243088
bibo:pmid
23280567
has license
cc-by
sha1sum (hex)
fac9ef6ba1ca4bdb16baad83f0146e6a5c3b906f
schema:url
https://doi.org/10.1002/eji.201243088
resource representing a document's title
Conditional ligands for Asian HLA variants facilitate the definition of CD8(+) T-cell responses in acute and chronic viral diseases
has PubMed Central identifier
PMC3655610
has PubMed identifier
23280567
schema:publication
Eur J Immunol
resource representing a document's body
covid:fac9ef6ba1ca4bdb16baad83f0146e6a5c3b906f#body_text
is
schema:about
of
named entity 'T-CELL'
named entity 'RESPONSES'
named entity 'mer'
named entity 'CHRONIC'
named entity 'ACUTE'
named entity 'JOURNAL '
named entity 'VIRAL DISEASES'
named entity 'PEPTIDES'
named entity 'SUPPORTING INFORMATION'
named entity 'OVERLAPPING'
named entity 'PEPTIDE'
named entity 'TOTAL'
named entity 'VARIANTS'
named entity 'DERIVED'
named entity 'HLA'
named entity 'CD8'
named entity 'LIGANDS'
named entity 'EUROPEAN'
named entity 'TESTED FOR'
named entity 'ASIAN'
named entity 'IMMUNOLOGY'
named entity 'CONDITIONAL'
named entity 'SUPPORTING INFORMATION'
named entity 'TO STABILIZE'
named entity 'FIGURE'
named entity 'THEIR'
named entity 'DIFFERENT'
named entity 'ANTIGEN'
named entity 'DEFINITION'
named entity 'CAPABILITY'
named entity 'DESIGN'
named entity 'MER'
named entity 'HLA'
named entity 'mer'
named entity 'tested'
named entity 'total'
named entity 'T-cell'
named entity 'T-cell'
named entity 'CD8 +'
named entity 'ligands'
named entity 'solid phase peptide synthesis'
named entity 'antigens'
named entity 'HLA'
named entity 'ligands'
named entity 'PBMCs'
named entity 'm/z'
named entity 'CD8'
named entity 'staining'
named entity 'Culturing'
named entity 'isomers'
named entity 'FlowJo'
named entity 'antigen'
named entity 'peptides'
named entity 'forward scatter'
named entity 'forward scatter'
named entity 'EBV'
named entity 'mass to charge ratios'
named entity 'negative staining'
named entity 'serum'
named entity 'C18'
named entity 'tetramer'
named entity 'HLA'
named entity 'amino acid sequences'
named entity 'isomers'
named entity 'RPMI'
named entity 'isomers'
named entity 'antibodies'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 2
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software